市場調査レポート
商品コード
1405904

リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCRの市場規模、シェア、動向分析レポート:技術別、製品別、用途別、地域別、セグメント動向:2024年~2030年

Real-time PCR, Digital PCR, And End-point PCR Market Size, Share & Trends Analysis Report By Technology (Quantitative, Digital, End-point), By Product, By Application, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCRの市場規模、シェア、動向分析レポート:技術別、製品別、用途別、地域別、セグメント動向:2024年~2030年
出版日: 2023年12月28日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場の成長と動向:

Grand View Research, Incの最新レポートによると、世界のリアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場規模は、2024年から2030年まで4.2%のCAGRを記録し、2030年までに71億8,000万米ドルに達すると予測されています。

しかし、COVID-19パンデミックの影響を除いた本当の世界のリアルタイムPCR、デジタルPCR、エンドポイントPCR市場は、2023年から2030年まで8.7%の複合年間成長率(CAGR)で拡大すると予測されています。デジタルPCRは、類似の多数配列の存在下で少数配列を絶対定量・分析する新しい技術です。dPCRは正確で高感度な核酸測定を可能にします。加えて、リアルタイムPCRは、疾患の正確で早期診断を提供し、迅速で的を絞った患者ケアを提供します。

肺がん、血液がん、脳腫瘍のような疾病の増加が世界市場のアプリケーション拡大に拍車をかけています。Globocan 2020によると、肺がんは欧州で2番目に多いがんで、新たに診断された症例は477,534例と推定されています。さらに、リアルタイムポリメラーゼ連鎖反応や定量ポリメラーゼ連鎖反応のような従来の技術に対するデジタルポリメラーゼ連鎖反応の利点は、予測期間を通じて採用を促進すると思われます。さらに、新興国におけるヘルスケア支出の増加と、正確な分子疾患検出のニーズの高まりが、市場の成長を促進しています。

さらに、COVID-19の大流行がデジタルPCR装置と試薬の需要を高めています。COVID-19感染は、分子診断技術として最新のデジタルPCR機器を使って検出されます。WHOによると、2021年12月現在、COVID-19により世界中で約2億7,300万人の症例が診断され、およそ530万人の死亡が記録されています。さらに製薬業界では、デジタルPCR装置は研究開発にも採用されています。

さらに、技術の進歩や世界市場における製品上市数の増加が、市場の成長を支えるものと期待されています。例えば、2021年6月、Bio-Rad Laboratories, Inc.は、COVID-19廃水スクリーニング用PREvalence ddPCR SARS-CoV-2廃水定量キットの発売を発表しました。

さらに、技術の進歩のための研究開発プロジェクトの増加や、デジタルポリメラーゼ連鎖反応の開発のための企業間の協力関係の増加が、PCR検査の利用を増加させると予想されます。例えば、キアゲンは2022年1月にAtila BioSystems &Actome GmbHと提携し、非侵襲的出生前検査(NIPT)技術をQIAGENのdPCRに提供することで、QIAcuityのアプリケーション数を増加させています。その結果、リアルタイムPCRとデジタルPCR技術の使用は予測期間中に増加すると予測されています。

リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場レポートハイライト:

  • 技術別では、定量PCRセグメントが2023年に83.34%以上の最大の収益シェアを占めました。これは、COVID-19のスクリーニングと診断のためのリアルタイムポリメラーゼ連鎖反応に基づく製品のイントロダクション支えられた技術の高い採用によるものです。
  • 消耗品および試薬セグメントは、早期検出に対する需要の増加と、デジタルPCR消耗品および試薬を製造する重要な企業の数により、2023年に62.62%以上の最大の収益シェアを占めました。
  • 北米は、高い研究開発投資の存在、技術的に高度なヘルスケア研究の枠組みの利用可能性、著名なポリメラーゼ連鎖反応製造業者の強力な存在、同地域における迅速診断検査への要求の拡大により、2023年に35.94%を超える収益シェアで市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場- 業界の展望

  • 市場系統の見通し
  • 市場力学
  • 比較解析
  • SWOT分析、要因別(政治・法律、経済・技術)
  • 業界分析- ポーターのファイブフォース分析

第4章 リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場分析、技術範囲、2018年~2030年

  • リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場:技術変動分析
  • 定量的
    • 定量的な市場推計・予測、2018年~2030年
    • 消耗品と試薬
    • 機器
    • ソフトウェアとサービス
  • デジタル
    • デジタル市場推計・予測、2018年~2030年
    • 消耗品と試薬
    • 機器
    • ソフトウェアとサービス
  • エンドポイントPCR
    • エンドポイントPCR市場推計・予測、2018年~2030年
    • 消耗品と試薬
    • 機器
    • ソフトウェアとサービス

第5章 リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場分析、製品範囲、2018年~2030年

  • リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場:製品変動分析
  • 消耗品と試薬
    • 消耗品および試薬市場推計・予測、2018年~2030年
  • 機器
    • 機器市場推計・予測、2018年~2030年
  • ソフトウェア・サービス
    • ソフトウェア・サービス市場推計・予測、2018年~2030年

第6章 リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場分析、用途、2018年~2030年

  • リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場:用途の変動分析
  • 臨床
    • 臨床市場推計・予測、2018年~2030年
    • 病原体検査
    • 腫瘍学検査
    • 血液検査
    • リキッドバイオプシー検査
    • DPCRベースの非侵襲的出生前検査(Nipt)
    • その他
  • 研究
    • 市場推計・予測、2018年~2030年を調査
    • 幹細胞調査
    • DNAクローニングと配列決定
    • 組換えDNA技術
    • まれな突然変異の検出
    • 遺伝子発現
    • 単一細胞解析
    • マイクロバイオーム分析
    • コピー数変異解析
    • ライブラリーの定量化(NG)
    • mrnaおよびmirna発現における低倍率変化の特徴付け
    • 種の識別
    • GMOの検出
  • 法医学およびその他

第7章 リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場分析、地域、2018年~2030年

  • 国別市場シェア分析、2023年および2030年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ

第8章 リアルタイムPCR(qPCR)、エンドポイント PCR、およびdPCR市場-競合情勢

  • 企業の分類
  • 戦略マッピング
    • 新製品の発売
    • パートナーシップ
    • 取得
    • コラボレーション
    • 資金調達
  • 主要企業の市場シェア分析、2023年
  • 企業プロファイル
    • Abbott
    • Qiagen
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Ge Healthcare
    • Biomerieux Sa
    • F. Hoffmann-La Roche Ltd
    • Fluidigm Corporation
図表

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies' /technology disruptors/innovators
  • Table 3 North America real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 7 North America qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 8 North America real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 10 North America real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 11 U.S. real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 15 U.S. qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 17 U.S. real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 18 U.S. real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 19 Canada real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Canada real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 21 Canada qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Canada qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 23 Canada qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Canada real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 25 Canada real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 26 Canada real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 27 Europe real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Europe real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 29 Europe qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Europe qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Europe qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Europe real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 33 Europe real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 34 Europe real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 35 U.K. real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 36 U.K. real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 37 U.K. qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 38 U.K. qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 39 U.K. qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 40 U.K. real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 41 U.K. real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 42 U.K. real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 43 Germany real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Germany real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 45 Germany qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Germany qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Germany qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Germany real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 49 Germany real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 50 Germany real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 51 Italy real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Italy real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 53 Italy qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Italy qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Italy qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Italy real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 57 Italy real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 58 Italy real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 59 Spain real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 60 Spain real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 61 Spain qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Spain qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Spain qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Spain real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 65 Spain real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 66 Spain real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 67 France real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 68 France real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 69 France qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 70 France qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 71 France qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 72 France real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 73 France real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 74 France real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 75 Denmark real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 76 Denmark real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 77 Denmark qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Denmark qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 79 Denmark qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Denmark real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 81 Denmark real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 82 Denmark real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 83 Sweden real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Sweden real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 85 Sweden qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 86 Sweden qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 87 Sweden qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Sweden real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 89 Sweden real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 90 Sweden real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 91 Norway real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 92 Norway real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 93 Norway qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 94 Norway qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 95 Norway qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 96 Norway real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 97 Norway real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 98 Norway real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 99 Asia Pacific real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 100 Asia Pacific real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 101 Asia Pacific qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 102 Asia Pacific qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Asia Pacific qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 104 Asia Pacific real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 105 Asia Pacific real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 106 Asia Pacific real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 107 China real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 108 China real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 109 China qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 110 China qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 111 China qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 112 China real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 113 China real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 114 China real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 115 Japan real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 116 Japan real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 117 Japan qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 118 Japan qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 119 Japan qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 120 Japan real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 121 Japan real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 122 Japan real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 123 India real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 124 India real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 125 India qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 126 India qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 127 India qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 128 India real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 129 India real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 130 India real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 131 Australia real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 132 Australia real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 133 Australia qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 134 Australia qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 135 Australia qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 136 Australia real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 137 Australia real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 138 Australia real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 139 South Korea real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 140 South Korea real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 141 South Korea qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 142 South Korea qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 143 South Korea qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 144 South Korea real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 145 South Korea real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 146 South Korea
  • Table 147 Thailand real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 148 Thailand real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 149 Thailand qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 150 Thailand qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 151 Thailand qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 152 Thailand real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 153 Thailand real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 154 Thailand real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 155 Latin America real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 156 Latin America real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 157 Latin America qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 158 Latin America qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 159 Latin America qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 160 Latin America real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 161 Latin America real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 162 Latin America real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 163 Brazil real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 164 Brazil real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 165 Brazil qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 166 Brazil qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 167 Brazil qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 168 Brazil real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 169 Brazil real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 170 Brazil real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 171 Mexico real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 172 Mexico real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 173 Mexico qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 174 Mexico qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 175 Mexico qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 176 Mexico real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 177 Mexico real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 178 Mexico real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 179 Argentina real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 180 Argentina real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 181 Argentina qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 182 Argentina qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 183 Argentina qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 184 Argentina real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 185 Argentina real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 186 Argentina real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 187 MEA real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 188 MEA real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 189 MEA qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 190 MEA qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 191 MEA qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 192 MEA real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 193 MEA real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 194 MEA real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 195 South Africa real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 196 South Africa real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 197 South Africa qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 198 South Africa qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 199 South Africa qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 200 South Africa real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 201 South Africa real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 202 South Africa real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 203 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 204 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 205 Saudi Arabia qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 206 Saudi Arabia qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 207 Saudi Arabia qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 208 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 209 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 210 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 211 UAE real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 212 UAE real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 213 UAE qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 214 UAE qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 215 UAE qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 216 UAE real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 217 UAE real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 218 UAE real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)
  • Table 219 Kuwait real time PCR, digital PCR and end-point PCR market, by technology, 2018 - 2030 (USD Million)
  • Table 220 Kuwait real time PCR, digital PCR and end-point PCR market, by product, 2018 - 2030 (USD Million)
  • Table 221 Kuwait qPCR and dPCR consumables & reagents market, by technology, 2018 - 2030 (USD Million)
  • Table 222 Kuwait qPCR and dPCR instruments market, by technology, 2018 - 2030 (USD Million)
  • Table 223 Kuwait qPCR and dPCR software & services market, by technology, 2018 - 2030 (USD Million)
  • Table 224 Kuwait real time PCR, digital PCR and end-point PCR market, by application, 2018 - 2030 (USD Million)
  • Table 225 Kuwait real time PCR, digital PCR and end-point PCR market, by clinical application, 2018 - 2030 (USD Million)
  • Table 226 Kuwait real time PCR, digital PCR and end-point PCR market, by research application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Real-time PCR (qPCR), end point PCR, and dPCR market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Real-time PCR (qPCR), end point PCR, and dPCR market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Real-time PCR (qPCR), end point PCR, and dPCR market driver impact
  • Fig. 14 Real-time PCR (qPCR), end point PCR, and dPCR market restraint impact
  • Fig. 15 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Ansoff Matrix
  • Fig. 19 Competitive dashboard analysis
  • Fig. 20 Regional network map
  • Fig. 21 Real-time PCR (qPCR), end point PCR, and dPCR market: Technology outlook and key takeaways
  • Fig. 22 Real-time PCR (qPCR), end point PCR, and dPCR market: Technology movement analysis& market share 2023 & 2030
  • Fig. 23 Quantitative market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 24 Digital market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 End-point PCR market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 26 Real-time PCR (qPCR), end point PCR, and dPCR market: Products outlook and key takeaways
  • Fig. 27 Real-time PCR (qPCR), end point PCR, and dPCR market: Products movement analysis & market share 2023 & 2030
  • Fig. 28 Consumables & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Software & services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Real-time PCR (qPCR), end point PCR, and dPCR market: Application outlook and key takeaways
  • Fig. 32 Real-time PCR (qPCR), end point PCR, and dPCR market: Application movement analysis & market share 2023 & 2030
  • Fig. 33 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Pathogen testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Oncology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Blood screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Liquid Biopsy testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 dPCR-based Non-Invasive Prenatal Testing (NIPT) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Stem cell research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 DNA cloning & sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Recombinant DNA technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Rare mutation detection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Gene expression market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Single-cell analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Microbiome analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Copy number variation analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Library quantification (NGS) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Characterization of low-fold changes in mRNA and miRNA expression market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Species identification market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 GMO detection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Forensics and others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Real-time PCR (qPCR), end point PCR, and dPCR market: Regional outlook and key takeaways
  • Fig. 55 Regional outlook, 2023 & 2030
  • Fig. 56 North America
  • Fig. 57 North America. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 U.S.
  • Fig. 59 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Canada
  • Fig. 61 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Europe
  • Fig. 63 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 UK
  • Fig. 65 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Germany
  • Fig. 67 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 France
  • Fig. 69 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Italy
  • Fig. 71 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Spain
  • Fig. 73 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Denmark
  • Fig. 75 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Sweden
  • Fig. 77 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Norway
  • Fig. 79 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Asia-Pacific
  • Fig. 81 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Japan
  • Fig. 83 Japan market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 84 India
  • Fig. 85 India. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 China
  • Fig. 87 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Australia
  • Fig. 89 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea
  • Fig. 91 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Thailand
  • Fig. 93 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Latin America
  • Fig. 95 Latin America. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Brazil
  • Fig. 97 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Mexico
  • Fig. 99 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Argentina
  • Fig. 101 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Middle East & Africa
  • Fig. 103 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 South Africa
  • Fig. 105 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 Saudi Arabia
  • Fig. 107 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 UAE
  • Fig. 109 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 110 Kuwait
  • Fig. 111 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-552-6

Real-time PCR, Digital PCR, And End-point PCR Market Growth & Trends:

The global real-time PCR, digital PCR, and end-point PCR market size is expected to reach USD 7.18 billion by 2030, registering a CAGR of 4.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years

The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.

Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.

Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.

Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period.

Real-time PCR, Digital PCR, And End-point PCR Market Report Highlights:

  • By technology, the Quantitative PCR segment held largest revenue share of over 83.34% in 2023. This is attributed to the high adoption of technology supported by the introduction of products based on real-time polymerase chain reaction for screening and diagnosis of COVID-19
  • The consumables and reagents segment held the largest revenue share of over 62.62% in 2023 due to the increased demand for earlier detection and the number of significant companies manufacturing digital PCR consumables and reagents
  • North America dominated the market with a revenue share of over 35.94% in 2023 due to the presence of high R&D investment, the availability of a technologically advanced healthcare research framework, the strong presence of prominent polymerase chain reaction manufacturers, and an expanding requirement for rapid diagnostic tests in the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Product Segment
    • 1.1.2 Technology Segment
    • 1.1.3 Application Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Summary
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Real-time PCR (qPCR) Market - Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers
      • 3.2.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
      • 3.2.1.2 Technological advancements in PCR
      • 3.2.1.3 Implementation of MIQE guidelines
      • 3.2.1.4 Increasing demand for rapid diagnostic tests and growing adoption of qPCR & dPCR technologies
      • 3.2.1.5 Increasing number of CROs and forensic & research laboratories
      • 3.2.1.6 Increasing demand for prenatal genetic testing procedures
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High device costs associated with Real time PCR (qPCR)
      • 3.2.2.2 Stringent regulatory policies
  • 3.3 Comparative Analysis
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's

Chapter 4 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Technology Scope, 2018 - 2030 (Revenue, USD Million)

  • 4.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Technology Movement Analysis
  • 4.2 Quantitative
    • 4.2.1 Quantitative Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.2 Consumables & Reagents
      • 4.2.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.3 Instruments
      • 4.2.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.4 Software & Services
      • 4.2.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Digital
    • 4.3.1 Digital Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.2 Consumables & Reagents
      • 4.3.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.3 Instruments
      • 4.3.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.4 Software & Services
      • 4.3.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4 End-Point Pcr
    • 4.4.1 End-Point Pcr Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.2 Consumables & Reagents
      • 4.4.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.3 Instruments
      • 4.4.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.4 Software & Services
      • 4.4.4.1 Software & services market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Product Scope, 2018 - 2030 (Revenue, USD Million)

  • 5.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Products Movement Analysis
  • 5.2 Consumables & Reagents
    • 5.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Instruments
    • 5.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Software & Services
    • 5.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Application Scope, 2018 - 2030 (Revenue, USD Million)

  • 6.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Application Movement Analysis
  • 6.2 Clinical
    • 6.2.1 Clinical Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Pathogen Testing
      • 6.2.2.1 Pathogen Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.3 Oncology Testing
      • 6.2.3.1 Oncology Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.4 Blood Screening
      • 6.2.4.1 Blood Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.5 Liquid Biopsy Testing
      • 6.2.5.1 Liquid Biopsy Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.6 Dpcr-Based Non-Invasive Prenatal Testing (Nipt)
      • 6.2.6.1 Dpcr-Based Non-Invasive Prenatal Testing (Nipt) Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.7 Others
      • 6.2.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Research
    • 6.3.1 Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2 Stem Cell Research
      • 6.3.2.1 Stem Cell Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.3 Dna Cloning & Sequencing
      • 6.3.3.1 Dna Cloning & Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.4 Recombinant Dna Technology
      • 6.3.4.1 Recombinant Dna Technology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.5 Rare Mutation Detection
      • 6.3.5.1 Rare Mutation Detection Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.6 Gene Expression
      • 6.3.6.1 Gene Expression Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.7 Single-Cell Analysis
      • 6.3.7.1 Single-Cell Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.8 Microbiome Analysis
      • 6.3.8.1 Microbiome Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.9 Copy Number Variation Analysis
      • 6.3.9.1 Copy Number Variation Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.10 Library Quantification (Ngs)
      • 6.3.10.1 Library Quantification (Ngs) Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.11 Characterization Of Low-Fold Changes In Mrna And Mirna Expression
      • 6.3.11.1 Characterization Of Low-Fold Changes In Mrna And Mirna Expression Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.12 Species Identification
      • 6.3.12.1 Species identification market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.13 GMO Detection
      • 6.3.13.1 GMO detection market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4 Forensics and Others
      • 6.4.1.1 Forensics and others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Regional Scope, 2018 - 2030 (Revenue, USD Million)

  • 7.1 Market Share Analysis by Country, 2023 & 2030
    • 7.1.1 North America
      • 7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.1.2 U.S.
      • 7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.1.2.2 Key country dynamics
      • 7.1.1.2.3 Competitive scenario
      • 7.1.1.2.4 Regulatory framework
      • 7.1.1.3 Canada
      • 7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.1.3.2 Key country dynamics
      • 7.1.1.3.3 Competitive scenario
      • 7.1.1.3.4 Regulatory framework
    • 7.1.2 Europe
      • 7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.2 UK
      • 7.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.2.2 Key country dynamics
      • 7.1.2.2.3 Competitive scenario
      • 7.1.2.2.4 Regulatory framework
      • 7.1.2.3 Germany
      • 7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.3.2 Key country dynamics
      • 7.1.2.3.3 Competitive scenario
      • 7.1.2.3.4 Regulatory framework
      • 7.1.2.4 France
      • 7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.4.2 Key country dynamics
      • 7.1.2.4.3 Competitive scenario
      • 7.1.2.4.4 Regulatory framework
      • 7.1.2.5 Italy
      • 7.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.5.2 Key country dynamics
      • 7.1.2.5.3 Competitive scenario
      • 7.1.2.5.4 Regulatory framework
      • 7.1.2.6 Spain
      • 7.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.6.2 Key country dynamics
      • 7.1.2.6.3 Competitive scenario
      • 7.1.2.6.4 Regulatory framework
      • 7.1.2.7 Denmark
      • 7.1.2.7.1 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.7.2 Key country dynamics
      • 7.1.2.7.3 Competitive scenario
      • 7.1.2.7.4 Regulatory framework
      • 7.1.2.8 Sweden
      • 7.1.2.8.1 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.8.2 Key country dynamics
      • 7.1.2.8.3 Competitive scenario
      • 7.1.2.8.4 Regulatory framework
      • 7.1.2.9 Norway
      • 7.1.2.9.1 Norway market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.9.2 Key country dynamics
      • 7.1.2.9.3 Competitive scenario
      • 7.1.2.9.4 Regulatory framework
    • 7.1.3 Asia-Pacific
      • 7.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.2 Japan
      • 7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.2.2 Key country dynamics
      • 7.1.3.2.3 Competitive scenario
      • 7.1.3.2.4 Regulatory framework
      • 7.1.3.3 India
      • 7.1.3.3.1 India market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.3.2 Key country dynamics
      • 7.1.3.3.3 Competitive scenario
      • 7.1.3.3.4 Regulatory framework
      • 7.1.3.4 Australia
      • 7.1.3.4.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.4.2 Key country dynamics
      • 7.1.3.4.3 Competitive scenario
      • 7.1.3.4.4 Regulatory framework
      • 7.1.3.5 China
      • 7.1.3.5.1 China market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.5.2 Key country dynamics
      • 7.1.3.5.3 Competitive scenario
      • 7.1.3.5.4 Regulatory framework
      • 7.1.3.6 South Korea
      • 7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.6.2 Key country dynamics
      • 7.1.3.6.3 Competitive scenario
      • 7.1.3.6.4 Regulatory framework
      • 7.1.3.7 Thailand
      • 7.1.3.7.1 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.7.2 Key country dynamics
      • 7.1.3.7.3 Competitive scenario
      • 7.1.3.7.4 Regulatory framework
    • 7.1.4 Latin America
      • 7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.4.2 Brazil
      • 7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.4.2.2 Key country dynamics
      • 7.1.4.2.3 Competitive scenario
      • 7.1.4.2.4 Regulatory framework
      • 7.1.4.3 Mexico
      • 7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.4.3.2 Key country dynamics
      • 7.1.4.3.3 Competitive scenario
      • 7.1.4.3.4 Regulatory framework
      • 7.1.4.4 Argentina
      • 7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.4.4.2 Key country dynamics
      • 7.1.4.4.3 Competitive scenario
      • 7.1.4.4.4 Regulatory framework
    • 7.1.5 Middle East & Africa
      • 7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.5.2 South Africa
      • 7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.5.2.2 Key country dynamics
      • 7.1.5.2.3 Competitive scenario
      • 7.1.5.2.4 Regulatory framework
      • 7.1.5.3 Saudi Arabia
      • 7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.5.3.2 Key country dynamics
      • 7.1.5.3.3 Competitive scenario
      • 7.1.5.3.4 Regulatory framework
      • 7.1.5.4 UAE
      • 7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.5.4.2 Key country dynamics
      • 7.1.5.4.3 Competitive scenario
      • 7.1.5.4.4 Regulatory framework
      • 7.1.5.5 Kuwait
      • 7.1.5.5.1 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.5.5.2 Key country dynamics
      • 7.1.5.5.3 Competitive scenario
      • 7.1.5.5.4 Regulatory framework

Chapter 8 Real-time PCR (qPCR), end point PCR, and dPCR Market - Competitive Landscape

  • 8.1 Company Categorization
  • 8.2 Strategy Mapping
    • 8.2.1 New Product Launch
    • 8.2.2 Partnerships
    • 8.2.3 Acquisition
    • 8.2.4 Collaboration
    • 8.2.5 Funding
  • 8.3 Key Company Market Share Analysis, 2023
  • 8.4 Company Profiles
    • 8.4.1 Abbott
      • 8.4.1.1 Company Overview
      • 8.4.1.2 Financial Performance
      • 8.4.1.3 Product Benchmarking
      • 8.4.1.4 Strategic Initiatives
    • 8.4.2 Qiagen
      • 8.4.2.1 Company Overview
      • 8.4.2.2 Financial Performance
      • 8.4.2.3 Product Benchmarking
      • 8.4.2.4 Strategic Initiatives
    • 8.4.3 Bio-Rad Laboratories, Inc.
      • 8.4.3.1 Company Overview
      • 8.4.3.2 Financial Performance
      • 8.4.3.3 Product Benchmarking
      • 8.4.3.4 Strategic Initiatives
    • 8.4.4 Agilent Technologies, Inc.
      • 8.4.4.1 Company Overview
      • 8.4.4.2 Financial Performance
      • 8.4.4.3 Product Benchmarking
      • 8.4.4.4 Strategic Initiatives
    • 8.4.5 Thermo Fisher Scientific, Inc.
      • 8.4.5.1 Company Overview
      • 8.4.5.2 Affymetrix
      • 8.4.5.3 Company Overview
      • 8.4.5.4 Financial Performance
      • 8.4.5.5 Product Benchmarking
      • 8.4.5.6 Strategic Initiatives
    • 8.4.6 Ge Healthcare
      • 8.4.6.1 Company Overview
      • 8.4.6.2 Financial Performance
      • 8.4.6.3 Product Benchmarking
      • 8.4.6.4 Strategic Initiatives
    • 8.4.7 Biomerieux Sa
      • 8.4.7.1 Company Overview
      • 8.4.7.2 Financial Performance
      • 8.4.7.3 Product Benchmarking
      • 8.4.7.4 Strategic Initiatives
    • 8.4.8 F. Hoffmann-La Roche Ltd
      • 8.4.8.1 Company Overview
      • 8.4.8.2 Financial Performance
      • 8.4.8.3 Product Benchmarking
      • 8.4.8.4 Strategic Initiatives
    • 8.4.9 Fluidigm Corporation
      • 8.4.9.1 Company Overview
      • 8.4.9.2 Financial Performance
      • 8.4.9.3 Product Benchmarking
      • 8.4.9.4 Strategic Initiatives